Lupin unveils Paliperidone ER Tablets in US Ruchika Sharma21 Oct 2022 11:26 AM ISTSchizophrenia is frequently associated with significant distress and impairment in personal, family, social, educational, occupational, and other...
Lupin to acquire two inhalation medicines from Sunovion Pharma for over Rs 623 crore Ruchika Sharma20 Oct 2022 12:15 PM ISTBrovana is indicated for long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including...
Lupin gets 17 USFDA observations for Pune facility Ruchika Sharma20 Oct 2022 11:20 AM IST"The Company does not believe that the 483 letter will have an impact on the existing revenues from operations of this facility," Lupin stated.
Lupin Gets CDSCO Panel nod To study LUBT017 Biosimilar to Eylea Dr. Divya Colin15 Oct 2022 6:00 PM ISTNew Delhi: Directing to appoint an independent data safety monitoring committee, the Subject Expert Committee (SEC) functional under Central Drug...
Lupin, Global Agencies collaborate to support tuberculosis prevention treatment Ruchika Sharma7 Oct 2022 2:30 PM ISTMumbai: Global pharma major, Lupin Limited has announced that it has reached an agreement with Unitaid, The Aurum Institute, the Clinton Health Access...
Lupin bags USFDA nod for HIV drug Darunavir Ruchika Sharma4 Oct 2022 3:16 PM ISTThe product will be manufactured at Lupin's facility in Nagpur, India.
Lupin gets USFDA EIR for Ankleshwar unit Ruchika Sharma3 Oct 2022 11:28 AM ISTThe inspection of the facility was conducted from August 16-19, 2022.
Lupin unveils generic equivalent of Revatio for Oral Suspension in US Ruchika Sharma30 Sept 2022 3:30 PM ISTThe medication is used to treat erectile dysfunction and pulmonary arterial hypertension.
Lupin bags USFDA approval for Mirabegron ER tablets to treat overactive bladder Ruchika Sharma30 Sept 2022 11:28 AM ISTThe product will be manufactured at Lupin's facility in Nagpur, India.
USFDA inspection: Lupin gets warning letter for Tarapur facility Ruchika Sharma29 Sept 2022 2:30 PM ISTMumbai: Pharma major, Lupin, has announced that the Company has received a warning letter from the US Food and Drug Administration (USFDA)...
Lupin bags USFDA nod for Diclofenac Sodium Topical Solution to treat arthritic knee pain Ruchika Sharma23 Sept 2022 11:15 AM ISTThe product will be manufactured at Lupin's facility in Pithampur, India.
Gilead Sciences settles patent disputes with Lupin, Cipla and 3 others over HIV, Hepatitis B drugs generic versions Ruchika Sharma16 Sept 2022 5:28 PM ISTThe generic drugmakers argued that the patents were invalid and unenforceable. They said in an August court filing that Gilead's patents covered...
